{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:04:33Z","timestamp":1792184673907,"version":"4.4.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.beem.2016.11.007","type":"journal-article","created":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T02:02:07Z","timestamp":1479434527000},"page":"795-804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["GH deficiency in adult survivors of childhood cancer"],"prefix":"10.1016","volume":"30","author":[{"given":"Francesco","family":"Felicetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Fortunati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Arvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Brignardello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2016.11.007_bib1","series-title":"SEER cancer statistics review, 1975e2009 (Vintage 2009 populations)","year":"2012"},{"key":"10.1016\/j.beem.2016.11.007_bib2","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N.\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2016.11.007_bib3","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2008.21.1425","article-title":"Late mortality among 5-Year survivors of childhood Cancer: a summary from the childhood Cancer survivor study","volume":"27","author":"Armstrong","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beem.2016.11.007_bib4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1530\/EJE-12-1043","article-title":"Endocrine health conditions in adult survivors of childhood cancer: the need for specialized adult-focused follow-up clinics","volume":"168","author":"Brignardello","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2016.11.007_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrendo.2016.45","article-title":"Late endocrine effects of childhood cancer","volume":"12","author":"Rose","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2016.11.007_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MED.0000000000000029","article-title":"Update on endocrine and metabolic therapy-related late effects observed in survivors of childhood neoplasia","volume":"21","author":"Chemaitilly","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.beem.2016.11.007_bib7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ctrv.2009.06.004","article-title":"Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: a systematic review","volume":"35","author":"Mulder","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.beem.2016.11.007_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11102-008-0088-4","article-title":"Hypopituitarism following radiotherapy","volume":"12","author":"Darzy","year":"2009","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2016.11.007_bib9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/cen.12969","article-title":"Pituitary dysfunction following cranial radiotherapy for adult-onset nonpituitary brain tumours","volume":"84","author":"Kyriakakis","year":"2016","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2016.11.007_bib10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12020-015-0840-2","article-title":"Considering GH replacement for GH-deficient adults with a previous history of cancer: a conundrum for the clinician","volume":"52","author":"Yuen","year":"2016","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.beem.2016.11.007_bib11","doi-asserted-by":"crossref","DOI":"10.1097\/MED.0b013e3283631820","article-title":"Radiation-induced hypopituitarism","volume":"20","author":"Darzy","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.beem.2016.11.007_bib12","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1097\/MPH.0b013e31821bbe7a","article-title":"Effects of growth hormone therapy on bone mass, metabolic balance and well-being in young adult survivors of childhood acute lymphoblastic leukemia","volume":"33","author":"Van den Heijkant","year":"2011","journal-title":"J\u00a0Pediatr Haematol Oncol"},{"key":"10.1016\/j.beem.2016.11.007_bib13","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1210\/jc.2004-0832","article-title":"The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy","volume":"90","author":"Mukherjee","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2016.11.007_bib14","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-15-0873","article-title":"GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults","volume":"174","author":"Allen","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2016.11.007_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1210\/jc.2002-021094","article-title":"The usefulness of the growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval","volume":"88","author":"Darzy","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2016.11.007_bib16","first-page":"274","article-title":"Effect of growth hormone-releasing factor on growth hormone release in children wit radiation induced growth hormone deficiency","volume":"76","author":"Lustig","year":"1985","journal-title":"Pediatrics"},{"key":"10.1016\/j.beem.2016.11.007_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000053232","article-title":"Growth hormone response to a growth hormone-releasing hormone stimulation test in a population-based study following cranial irradiation of childhood brain tumors","volume":"54","author":"Schmiegelow","year":"2000","journal-title":"Hormone Res"},{"key":"10.1016\/j.beem.2016.11.007_bib18","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1210\/jc.2004-2002","article-title":"The dynamics of GH secretion in adult cancer survivors with severe GH deficiency acquired after brain irradiation in childhood for non pituitary brain tumors: evidence for preserved pulsatility and diurnal variation with increase secretory disorderliness","volume":"90","author":"Darzy","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2016.11.007_bib19","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1210\/jc.2006-2599","article-title":"Cranial irradiation and growth hormone neurosecretory dysfunction: a critical appraisal","volume":"92","author":"Darzy","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2016.11.007_bib20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2265.2008.03359.x","article-title":"Cranially irradiated adult cancer survivors may have normal spontaneous GH secretion in the presence of discordant peak GH response to stimulation tests (compensated GH deficiency)","volume":"70","author":"Darzy","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2016.11.007_bib21","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0022-3476(05)80487-1","article-title":"Dose dependency of time of onset of radiation-induced growth hormone deficiency","volume":"118","author":"Clayton","year":"1991","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.beem.2016.11.007_bib22","first-page":"165","article-title":"Effects of cranial irradiation on hypothalamic-pituitary function\u2013a 5-year longitudinal study in patients with nasopharyngeal carcinoma","volume":"78","author":"Lam","year":"1991","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.beem.2016.11.007_bib23","first-page":"145","article-title":"Hypopituitarism following external radiotherapy for pituitary tumours in adults","volume":"70","author":"Littley","year":"1989","journal-title":"Q\u00a0J Med"},{"issue":"Suppl A","key":"10.1016\/j.beem.2016.11.007_bib24","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.ghir.2006.03.002","article-title":"Pathophysiology of radiation-induced growth hormone deficiency: efficacy and safety of GH replacement","volume":"16","author":"Darzy","year":"2006","journal-title":"Growth Hormone IGF Res"},{"key":"10.1016\/j.beem.2016.11.007_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/MOP.0b013e3282058b56","article-title":"Long-term endocrine sequelae of childhood cancer","volume":"19","author":"Rutter","year":"2007","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.beem.2016.11.007_bib26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2307\/3575908","article-title":"The effect of single-dose radiation on cell survival and growth hormone secretion by rat anterior pituitary cells","volume":"94","author":"Hochberg","year":"1983","journal-title":"Radiat Res"},{"key":"10.1016\/j.beem.2016.11.007_bib27","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1046\/j.1365-2265.1998.00438.x","article-title":"Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood","volume":"48","author":"Brennan","year":"1998","journal-title":"Clin Endocrinol Oxf"},{"key":"10.1016\/j.beem.2016.11.007_bib28","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1651-2227.1990.tb11357.x","article-title":"Growth and growth hormone secretion in children following treatment of brain tumours with radiotherapy","volume":"79","author":"Darendeliler","year":"1990","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.beem.2016.11.007_bib29","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.1542\/peds.103.3.e37","article-title":"Growth failure after treatment of pediatric brain tumors","volume":"103","author":"Clarson","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.beem.2016.11.007_bib30","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1651-2227.1988.tb10815.x","article-title":"Growth hormone secretion and response to growth hormone therapy after treatment for brain tumour","volume":"343","author":"Lannering","year":"1988","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.beem.2016.11.007_bib31","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s004310050708","article-title":"Growth impairment and growth hormone therapy in children treated for malignant brain tumours","volume":"156","author":"Ilveskoski","year":"1997","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.beem.2016.11.007_bib32","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/BF00442471","article-title":"Growth response to growth hormone therapy following craniospinal irradiation","volume":"147","author":"Clayton","year":"1988","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.beem.2016.11.007_bib33","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1200\/JCO.1991.9.3.400","article-title":"Abnormal growth patterns and adult short stature in 115 long term survivors of childhood leukemia","volume":"9","author":"Schriock","year":"1991","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beem.2016.11.007_bib34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1203\/00006450-199306000-00008","article-title":"Long-term effects of treatment for acute lymphoblastic leukemia with and without cranial irradiation on growth and puberty: a comparative study","volume":"33","author":"Hokken-Koelega","year":"1993","journal-title":"Pediatr Res"},{"key":"10.1016\/j.beem.2016.11.007_bib35","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1651-2227.1988.tb10731.x","article-title":"Growth in children treated for acute lymphoblastic leukemia with and without prophylactic cranial irradiation","volume":"77","author":"Moell","year":"1988","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.beem.2016.11.007_bib36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/adc.53.6.491","article-title":"Growth impairment in children treated for brain tumours","volume":"53","author":"Shalet","year":"1978","journal-title":"Archives Dis Child"},{"key":"10.1016\/j.beem.2016.11.007_bib37","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1210\/jcem-68-2-346","article-title":"A\u00a0prospective study of the development of growth hormone deficiency in children given cranial irradiation, and its relation to statural growth","volume":"68","author":"Brauner","year":"1989","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2016.11.007_bib38","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/adc.58.9.722","article-title":"Savage Growth and endocrine function after treatment for medulloblastoma","volume":"58","author":"Brown","year":"1983","journal-title":"Archives Dis Child"},{"key":"10.1016\/j.beem.2016.11.007_bib39","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1651-2227.1987.tb17273.x","article-title":"A\u00a0longitudinal study on growth and spontaneous growth hormone (GH) secretion in children with irradiated brain tumors","volume":"76","author":"Albertsson-Wikland","year":"1987","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.beem.2016.11.007_bib40","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/1097-0142(19921001)70:7<2013::AID-CNCR2820700734>3.0.CO;2-J","article-title":"The effects of adjuvant chemotherapy on growth in children with medulloblastoma","volume":"70","author":"Olshan","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2016.11.007_bib41","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2003-030366","article-title":"Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement","volume":"88","author":"Gleeson","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2016.11.007_bib42","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1530\/EJE-09-0690","article-title":"Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience","volume":"162","author":"Beckers","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2016.11.007_bib43","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1177\/2047487314529348","article-title":"Prevalence of cardiovascular risk factors in long-term survivors of childhood cancer: 16 years follow up from a perspective registry","volume":"22","author":"Felicetti","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.beem.2016.11.007_bib44","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/annonc\/mdp414","article-title":"Components of metabolic syndrome in 500 adult long-term survivors of childhood cancer","volume":"21","author":"Van Waas","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beem.2016.11.007_bib45","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2265.2008.03283.x","article-title":"Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL)","volume":"69","author":"Steffens","year":"2008","journal-title":"Clin Endocrinol Oxf"},{"key":"10.1016\/j.beem.2016.11.007_bib46","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1001\/jama.2011.747","article-title":"Long-term risks of subsequent primary neoplasms among survivors of childhood cancer","volume":"305","author":"Reulen","year":"2011","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.beem.2016.11.007_bib47","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/S0140-6736(09)61885-7","article-title":"Second primary cancers in survivors of childhood cancer","volume":"374","author":"Oeffinger","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2016.11.007_bib48","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jnci\/djr533","article-title":"Second malignant neoplasms and cardiovascular disease following radiotherapy","volume":"104","author":"Travis","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.beem.2016.11.007_bib49","first-page":"4444","article-title":"Growth hormone treatment of children with brain tumors and risk of tumor recurrence","volume":"85","author":"Swerdlow","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2016.11.007_bib50","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1210\/jcem.87.7.8606","article-title":"Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivors Study","volume":"87","author":"Sklar","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2016.11.007_bib51","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2011-0112","article-title":"Long-term safety of growth hormone replacement after CNS irradiation","volume":"96","author":"Mackenzie","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2016.11.007_bib52","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00432-011-1004-2","article-title":"Endocrine late effects after total body irradiation in patients who received hematopoietic stem cells transplantation during childhood: a retrospective study from a single institution","volume":"137","author":"Felicetti","year":"2011","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.beem.2016.11.007_bib53","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1210\/jc.2006-0656","article-title":"Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor","volume":"91","author":"Ergun-Longmire","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2016.11.007_bib54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrendo.2010.171","article-title":"Growth hormone, the insulin-like growth factor axis, insulin and cancer risk","volume":"7","author":"Clayton","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2016.11.007_bib55","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2013-4159","article-title":"Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study","volume":"99","author":"Patterson","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2016.11.007_bib56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s40618-014-0179-1","article-title":"GH replacement therapy and second neoplasms in adult survivors of childhood cancer: a retrospective study from a single institution","volume":"38","author":"Brignardello","year":"2015","journal-title":"J\u00a0Endocrinol Investig"},{"key":"10.1016\/j.beem.2016.11.007_bib57","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1210\/jc.2012-2684","article-title":"Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients","volume":"98","author":"Hartman","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2016.11.007_bib58","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11102-013-0529-6","article-title":"Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the Hypopituitary Control and Complications Study (HypoCCS)","volume":"17","author":"Mo","year":"2013","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2016.11.007_bib59","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1080\/08035250600577889","article-title":"Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database)","volume":"95","author":"Darendeliler","year":"2006","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.beem.2016.11.007_bib60","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1530\/EJE-12-0967","article-title":"Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS","volume":"168","author":"Woodmansee","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2016.11.007_bib61","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1210\/jcem.87.1.8146","article-title":"GH-deficient survivors of childhood cancer: GH replacement during adult life","volume":"87","author":"Murray","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2016.11.007_bib62","first-page":"8","article-title":"The usefulness of growth hormone treatment for psychological status in young adult survivors of childhood leukaemia: an open-label study","volume":"20","author":"Huisman","year":"2008","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.beem.2016.11.007_bib63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/er.16.1.63","article-title":"Clinical aspects of growth hormone deficiency in adults","volume":"16","author":"De Boer","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2016.11.007_bib64","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism","volume":"336","author":"Rosen","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2016.11.007_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2013.00064","article-title":"Adult growth hormone deficiency \u2013 benefits side effects, and risks of growth hormone replacement","volume":"4","author":"Reed","year":"2013","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2016.11.007_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.15.S2.1","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients \u2013 2009 update","volume":"15","author":"Cook","year":"2009","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2016.11.007_bib67","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guidelines","volume":"96","author":"Molitch","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2016.11.007_bib68","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EC-16-0024","article-title":"Growth hormone deficiency during adulthood and the benefits of growth hormone replacement","volume":"5","author":"Ahmid","year":"2016","journal-title":"Endocr Connect"},{"key":"10.1016\/j.beem.2016.11.007_bib69","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ghir.2012.09.003","article-title":"The role of the insulin-like growth factor-I receptor in malignancy: an update","volume":"22","author":"Seccareccia","year":"2012","journal-title":"Growth Hormone IGF Res"},{"key":"10.1016\/j.beem.2016.11.007_bib70","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","article-title":"Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis","volume":"363","author":"Renehan","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2016.11.007_bib71","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1210\/jc.2009-1378","article-title":"Insulin-like growth factor-I and cancer mortality in older men","volume":"95","author":"Major","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2016.11.007_bib72","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/ijc.24927","article-title":"Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies","volume":"126","author":"Rinaldi","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beem.2016.11.007_bib73","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1470-2045(10)70095-4","article-title":"Insulin-like growth factor1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies","volume":"11","author":"The Endogenous Hormones and Breast Cancer Collaborative Group","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.beem.2016.11.007_bib74","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1210\/jc.2013-2415","article-title":"Update in mortality in GH-treated patients","volume":"98","author":"Erfurth","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2016.11.007_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.12477","article-title":"Efficacy and safety of growth hormone treatment in adults with growth hormone deficiency: a systematic review of studies on morbidity","volume":"81","author":"Van Bunderen","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2016.11.007_bib76","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ghir.2014.02.001","article-title":"Association between growth hormone therapy and mortality, cancer and cardiovascular risk: systematic review and meta-analysis","volume":"24","author":"Deodati","year":"2014","journal-title":"Growth Hormone IGF Res"},{"key":"10.1016\/j.beem.2016.11.007_bib77","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ghir.2015.06.006","article-title":"Reviewing the safety of GH replacement therapy in adults","volume":"25","author":"Stochholm","year":"2015","journal-title":"Growth Hormone IGF Res"},{"key":"10.1016\/j.beem.2016.11.007_bib78","series-title":"Overview","first-page":"27","article-title":"\u201cSafety\u201d","volume":"vol. 13","author":"KIMS (Pfizer International Metabolic Database)","year":"2010"},{"key":"10.1016\/j.beem.2016.11.007_bib79","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-14-1123","article-title":"Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study","volume":"172","author":"Child","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2016.11.007_bib80","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2015-1764","article-title":"Tumor recurrence or regrowth in adults with nonfunctioning pituitary adenomas using GH replacement therapy","volume":"100","author":"Van Varsseveld","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X16300732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X16300732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:51:44Z","timestamp":1761497504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X16300732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1521690X16300732"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2016.11.007","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727113476.793538660","asserted-by":"object"}]},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GH deficiency in adult survivors of childhood cancer","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2016.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}